Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336
- Citation:
- J Clin Oncol vol 27 (1) 11-15
- Year:
- 2009
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA-37404, CA-52352, CA-25267, CA-35195, CA-25224, CA-60276, CA-35113, CA-63848, CA-35119, CA-35415, CA-37417, CA-35448
- Corr. Author:
- Authors:
- Alvaro Moreno-Aspitia Roscoe F. Morton David W. Hillman Wilma L. Lingle Kendrith M. Rowland Martin Wiesenfeld Patrick J. Flynn Tom R. Fitch Edith A. Perez
- Networks:
- Study
- NCCTG-N0336
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Breast Cancer